United States — Food and Drug Administration & Johnson & Johnson

United States — Food and Drug Administration: The United States — Food and Drug Administration encourages the adoption of advanced manufacturing technologies and continuous production models, reinforcing the shift from reactive to proactive compliance strategies in the pharmaceutical industry.

Johnson & Johnson: Johnson & Johnson has invested in AI-powered platforms to enhance decision-making and streamline development processes, reflecting the industry's adoption of intelligent manufacturing.

United States — Food and Drug Administration: The United States — Food and Drug Administration advised doctors to consider minimizing acetaminophen's use in pregnancy, amid inconclusive evidence about a link to autism.

Johnson & Johnson: Johnson & Johnson spun off Kenvue two years prior to this acquisition, aiming to make its pharmaceutical and medical device divisions more nimble.

United States — Food and Drug Administration: The United States — Food and Drug Administration is currently reviewing the New Drug Application for rusfertide for the treatment of polycythemia vera.

Johnson & Johnson: Johnson & Johnson is the parent company of Johnson & Johnson — Janssen Pharmaceuticals, which is involved in the development and commercialization of ICOTYDE.